Suresh Ramalingam

@RamalingamMD

Professor, Thoracic Oncologist, Director of Medical Oncology, Emory University, Winship Cancer Institute. Opinions are my own.

Atlanta, GA
Vrijeme pridruživanja: srpanj 2009.

Tweetovi

Blokirali ste korisnika/cu @RamalingamMD

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RamalingamMD

  1. 3. velj

    Looking forward to this exciting symposium. Lots to discuss given recent advances in lung cancer! Abstract submission is open.

    Poništi
  2. 3. velj

    Welcome! We look forward to working with you.

    Poništi
  3. 30. sij

    Important publication from NELSON study. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial | NEJM

    Poništi
  4. 29. sij
    Poništi
  5. 26. sij

    Just be average Georgia! If we get tobacco taxes to national average, we will take a big step forward.(presently48th lowest in the country).

    Poništi
  6. 13. sij
    Poništi
  7. 10. sij
    Poništi
  8. proslijedio/la je Tweet
    9. sij

    U.S. cancer death rate sees its largest single-year drop – driven by precision medicine and in lung cancer. Thank you members for helping develop these advances! , IASLC's CSO, has issued the following response to the news.

    Poništi
  9. proslijedio/la je Tweet

    Today the American Cancer Society reported the biggest-ever one-year drop of the U.S. cancer mortality rate driven largely by progress in the treatment of . Winship lung cancer expert Suresh Ramalingam, MD, comments on this and looks ahead to more progress.

    Poništi
  10. 8. sij

    Lung cancer mortality reducing rapidly in the United States: if only we can increase adoption of CT screening, we can do even better! Cancer statistics, 2020

    Poništi
  11. 4. sij

    When these articles talk about improving resilience, I wonder if they are saying we lack resilience!

    Poništi
  12. 3. sij

    Sadly, this falls short of a complete ban on all flavored products! Addressing the problem at its periphery is not sufficient!

    Poništi
  13. proslijedio/la je Tweet

    2nd pre-call (after a long time in phone tree) to get "peer-to-peer" for Daratumumab for RRMM and told that my "peer" will be a pharmacist in Ohio. Isn't that practicing medicine without a medical license?

    Prikaži ovu nit
    Poništi
  14. proslijedio/la je Tweet
    18. pro 2019.

    Delighted to welcome Dr. Schildkraut to department and the Cancer Prevention and Control Program at !

    Poništi
  15. 17. pro 2019.

    Congrats to Dr. Everett Vokes on being elected as President-elect of .

    Poništi
  16. 16. pro 2019.
    Poništi
  17. 16. pro 2019.
    Poništi
  18. 15. pro 2019.
    Poništi
  19. proslijedio/la je Tweet

    Winship Executive Director Walter J. Curran, Jr., MD () remarks for on how far we've come in the last ten years. ➡️

    Poništi
  20. 12. pro 2019.

    Congrats to Dr. Rathi Pillai ⁦⁩ on this publication. ⁦

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·